• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    ESHA Research

    Atlantia Clinical Trials

    Sabinsa Corporation

    KLK OLEO
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    ESHA Research

    Atlantia Clinical Trials

    Sabinsa Corporation

    KLK OLEO
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation

    The present regulatory scheme is out of date and requires significant revisions to reflect modern realities.

    Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation
    Related CONTENT
    • Lanfam LLC Launches Medical Food for Pain Relief
    • High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children
    • Claims Spell Success in Today’s Nutritional Products Market
    • Personalized Health & The Future of Cannabis
    • Disrupting the Immune Health Category in 2021 & Beyond
    By Todd Harrison, Venable11.01.17
    In recent years, we have seen a proliferation of dietary supplement and functional food products being marketed as medical foods. Some of these products appear to have legitimate basis as they target populations with distinct nutritive needs. On the other hand, we have also seen significant growth in dietary supplement products masquerading as “medical foods,” consequently putting a vulnerable and unsuspecting public at risk. 

    Many of these products are targeting vulnerable patient populations, in particular the elderly, with claims related to Alzheimer’s, osteoarthritis, rheumatoid arthritis, and stroke. These products do not appear on their face to relate to “the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” (21 U.S.C. § 360ee(b)(3).)

    Rather, they appear positioned to justify the use of otherwise impermissible disease claims for dietary supplements. The FDA does not appear to believe there’s a need to address these products in a decisive manner. Rather, it continues to allow this pseudo-product category to grow, placing certain vulnerable patient populations at risk.

    To be sure, there is a valid place for legitimate medical food products that are based on sound nutritional science and clinical research. Indeed, given the breadth of claims the FDA believes are impermissible disease claims, it makes sense to expand those products that are rightfully considered to be appropriate options for many diseases that have clear nutritional underpinnings. Moreover, FDA’s narrow definition of a medical food excludes products that would be particularly beneficial to certain patient populations, including those with type 2 diabetes, Irritable Bowel Syndrome (IBS), and male fertility issues related to oxidative stress.  

    FDA’s overly restrictive view of what is considered a medical food is particularly troublesome. Without going into detail about FDA’s fatally restrictive position on medical foods, it is important to understand what the statutory framework for the Orphan Drug Act requires:

    • The product must be used under the supervision of a physician.
    • The substance must be recognized as a “food.” (Dietary supplements are foods under the Federal Food, Drug and Cosmetic Act.)
    • The product must be a food that is specifically formulated to be consumed enterally (taken by mouth).
    • The medical food must be for the “specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” 
    Ready or Not? 
    Over the years I have discussed how certain diseases or health-related conditions are ripe for medical foods, yet FDA does not believe this to be true. For instance, if there was ever a classic disease related to nutrition, it is type 2 diabetes or metabolic syndrome. (There is still some question whether FDA considers metabolic syndrome a disease or not.) The first intervention is not a prescription drug but lifestyle changes to maintain normal blood sugar levels. However, simply altering the diet is not necessarily an easy proposition, so it makes sense to permit targeted dietary ingredients in this definition.

    But how does a particular dietary ingredient meet this need if it is not based on what we would normally consider a nutritive effect? This may be more easily accomplished for those with IBS than type 2 diabetes. The literature is replete with the benefits of probiotics for IBS patients and the benefits of probiotics should be considered nutritive not pharmacological.

    Yet, FDA takes the position that probiotics are not appropriate medical foods for the dietary management of IBS. This position is likely related to the fact that individuals can do their own research and take a probiotic supplement, which is a simple modification to the diet. This interpretation strains credulity, as most IBS patients are not going to do the research or know the proper dosage to take to help manage their symptoms. Thus, by taking a blanket position that probitiocs are is not an appropriate medical food for IBS, the agency denies patients a dietary management tool that can have profound benefits.

    Another area to consider is male reproductive health. There is mounting evidence that oxidative stress can impact the quality of male sperm. The agency takes the position this is an implied male infertility claim, which it is not, in my mind. However, if we accept the agency’s position for the purpose of this column only, why should we not be able to develop a medical food that is specifically designed to lower the impact of oxidative stress on male fertility through the use of targeted antioxidants?  

    Access Restricted
    The purpose of this column is to demonstrate that we have reached a point within the present regulatory paradigm where access to products that provide real solutions are not readily available to consumers. Moreover, the agency feels constrained to restrict medical foods and claims for dietary supplements. Yet, on the medical food front, FDA fails to go after the most egregious actors; and on the dietary supplement front, the agency wrongfully believes that oxidative stress and male fertility, for example, is an implied disease claim.

    This confluent set of events causes more companies to either strain the definition of medical foods to include osteoarthritis, or develop claims (e.g., “supports blood sugar levels already in the normal range” or “supports joint comfort”) that have little value to consumers and patients. 

    Changing the Regulatory Paradigm
    To regular readers of this column, it is known that I have been a longtime advocate (to the dismay of some) that our regulatory paradigm must evolve to be consistent with reality and common sense. Rather than viewing health as a binary proposition between disease and health, we need to understand that many things FDA considers to be a disease are actually part of the normal aging process. For instance, I recently had an MRI that disclosed a partial tear in my rotator cuff, however, it also disclosed that I have the start of osteoarthritis in my elbow and shoulder, coupled with inflammation. As my doctor made clear, “you are 55 years old and this is a common part of aging even though it has a disease moniker attached to it.”

    My rotator cuff may need to be repaired if physical therapy does not work, but the osteoarthritis will remain. Under the present paradigm, I have one of two choices for pain relief: prescription drugs or OTC drugs, all of which have serious side effects related to long-term use. However, I also admit that I do not have a distinct nutritional need for curcumin or glucosamine. So where does this leave me? Fortunately, I know what works and what does not. But the typical consumer will need to decipher code words on a dietary supplement bottle or purchase a medical food that really isn’t a medical food. This situation does not make sense.

    Here’s a simple solution. Because the industry as a whole is afraid to reopen the Dietary Supplement Health and Education Act, I have a new proposal:

    • Reopen the definition of a medical food under the Orphan Drug Act to include dietary ingredients that have nutritive value or therapeutic value;
    • Permit dietary management claims for diseases that have a significant nutritional component (e.g., type 2 diabetes, stage 1 high blood pressure, IBS);
    • Permit therapeutic claims for all other conditions that are already permitted for OTC drugs (e.g., osteoarthritis, GERD, cough/cold);
    • Restrict those products intended to provide dietary management for more serious conditions, but still manageable through dietary intervention (e.g., type 2 diabetes, IBS) to be sold behind the counter without a prescription or through physician offices;
    • Require companies to list and register with FDA;
    • Require the submission of a dossier to FDA in support of the medical food’s safety and efficacy for the intended patient population;
               - Limit FDA’s review of the dossier;
               - FDA may only object if it is clear there is no basis for the product to be marketed as a dietary supplement;
               - Setup an independent third-party review process when FDA objects. 

    It’s clear the present regulatory scheme is out of date and requires significant revisions to reflect modern realities. More and more companies are entering the medical food arena because they view it as a large loophole to disease claims. Some of these medical foods are legitimate while some are not, but regardless, FDA seems unwilling to act decisively with those that are clearly not. On the other hand, we do not want to sweep away products that are legitmate and will help a significant number of individuals improve their health. The disease/health paradigm we have created is broken and cannot address the changes in society, flow of information, and the ability of rogue companies to market any product they choose.

    Bold action is required. We are not growing healthier in this country. People are sicker because we fail to understand that not everything is a disease that requires strong pharmaceutical intervention. The latter is certainly necessary, but think of the good we could create if we gave the supplement and pharmaceutical industries a path to development of nutritive products that are lawfully sold without fear of FDA or plaintiff class action lawyers who sue companies under state law because of disease claims.

    It is time for a change. Are we as an industry willing to lead that change, or will we continue to ignore problems that the primary statutory and regulatory framework has created? My hope is the former.


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Stress
    • Dietary Supplement
    • Dosage
    • Dietary Supplements
    Related Knowledge Center
    • Medical Nutrition
    • Healthcare Trends
    • Regulations
    Suggested For You
    Lanfam LLC Launches Medical Food for Pain Relief Lanfam LLC Launches Medical Food for Pain Relief
    High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children
    Claims Spell Success in Today’s Nutritional Products Market Claims Spell Success in Today’s Nutritional Products Market
    Personalized Health & The Future of Cannabis Personalized Health & The Future of Cannabis
    Disrupting the Immune Health Category in 2021 & Beyond Disrupting the Immune Health Category in 2021 & Beyond
    UNPA Offers Education and Training for Food and Supplement Companies UNPA Offers Education and Training for Food and Supplement Companies
    CRN to Host Interactive Medical Food Summit CRN to Host Interactive Medical Food Summit
    Dietary Supplement Caucus Briefing Covers Nutritional Intakes of U.S. Adults Dietary Supplement Caucus Briefing Covers Nutritional Intakes of U.S. Adults
    CRN Survey Finds Supplement Users Discuss Usage with Healthcare Practitioners CRN Survey Finds Supplement Users Discuss Usage with Healthcare Practitioners
    Testing Strategies in the  Modern Nutraceuticals Industry Testing Strategies in the Modern Nutraceuticals Industry
    Building on Quality Foundations Building on Quality Foundations
    Current Good Manufacturing Practices & the Private-Label Distributor Current Good Manufacturing Practices & the Private-Label Distributor
    Key Speakers for CRN Conference Announced Key Speakers for CRN Conference Announced
    FDA Concludes Major Sampling Study of Sprouts FDA Concludes Major Sampling Study of Sprouts
    FDA Guidance Explains Certain Exemptions from FSMA FDA Guidance Explains Certain Exemptions from FSMA

    Related Content

    • Breaking News | Herbs & Botanicals | Inflammation | Medical Nutrition | Products | Proteins, Peptides, Amino Acids
      Lanfam LLC Launches Medical Food for Pain Relief

      Lanfam LLC Launches Medical Food for Pain Relief

      Proleeva is formulated to address amino acid deficiencies seen in inflammatory disorders and chronic pain.
      03.21.22

    • Breaking News | Cognitive Function | Functional Foods & Beverages | Infant & Children's Health | Medical Nutrition | Natural/Organic | Omega-3s | Quality & Safety | Research | Research News
      High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children

      High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children

      The addition of DHA conferred a significant cognitive benefit six months after the completion of a diet therapy by thousands of severely malnourished children.
      12.01.21

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Quality & Safety | Regulations
      Claims Spell Success in Today’s Nutritional Products Market

      Claims Spell Success in Today’s Nutritional Products Market

      Products require meaningful claims supported by strong clinical substantiation and unquestionable safety.
      By Gregory Stephens, Windrose Partners 11.11.21


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Natural/Organic
      Personalized Health & The Future of Cannabis

      Personalized Health & The Future of Cannabis

      Len May, CEO & co-founder of EndoCanna Health, discusses his journey with cannabis and its potential to improve health for others.
      By Sheldon Baker, CEO of the Baker Dillon Group LLC 10.08.21

    • Disrupting the Immune Health Category in 2021 & Beyond

      Disrupting the Immune Health Category in 2021 & Beyond

      Register Now for our FREE Webinar!
      09.30.21

      Trending
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Senate Bill To Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision | Nutraceuticals World
      • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      • NMN Boosts Aerobic Capacity In Runners, Study Finds | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      Natura Launches Chronos Aqua-Plumping Bio-Hydrating Serum
      Silab Implements Biodiversity Conservation Project
      Indie Beauty Brand i-On Skincare Releases New Skin Emulsion, AI Diagnostic Tool
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login